首页> 外文期刊>Breast Cancer Research and Treatment >Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire-guided localisation’ (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial
【24h】

Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire-guided localisation’ (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial

机译:“放射引导性隐匿性病变定位”(ROLL)与“导线引导性定位”(WGL)在不可触及乳腺癌的保乳手术中的疗效:一项随机对照多中心试验

获取原文
获取原文并翻译 | 示例
       

摘要

For the management of non-palpable breast cancer, accurate pre-operative localisation is essential to achieve complete resection with optimal cosmetic results. Radioguided occult lesions localisation (ROLL) uses the radiotracer, injected intra-tumourally for sentinel lymph node identification to guide surgical excision of the primary tumour. In a multicentre randomised controlled trial, we determined if ROLL is superior to the standard of care (i.e. wire-guided localisation, WGL) for preoperative tumour localisation. Women (18 years.) with histologically proven non-palpable breast cancer and eligible for breast conserving treatment with sentinel node procedure were randomised to ROLL or WGL. Patients allocated to ROLL received an intra-tumoural dose of 120 Mbq technetium-99 m nanocolloid. The tumour was surgically removed, guided by gamma probe detection. In the WGL group, ultrasound- or mammography-guided insertion of a hooked wire provided surgical guidance for excision of the primary tumour. Primary outcome measures were the proportion of complete tumour excisions (i.e. with negative margins), the proportion of patients requiring re-excision and the volume of tissue removed. Data were analysed according to intention-to-treat principle. This study is registered at ClinincalTrials.gov, number NCT00539474. In total, 314 patients with 316 invasive breast cancers were enrolled. Complete tumour removal with negative margins was achieved in 140/162 (86 %) patients in the ROLL group versus 134/152 (88 %) patients in the WGL group (P = 0.644). Re-excision was required in 19/162 (12 %) patients in the ROLL group versus 15/152 (10 %) (P = 0.587) in the WGL group. Specimen volumes in the ROLL arm were significantly larger than those in the WGL arm (71 vs. 64 cm3, P = 0.017). No significant differences were seen in the duration and difficulty of the radiological and surgical procedures, the success rate of the sentinel node procedure, and cosmetic outcomes. In this first multicentre randomised controlled comparison of ROLL versus WGL in patients with histologically proven breast cancer, ROLL is comparable to WGL in terms of complete tumour excision and re-excision rates. ROLL, however, leads to excision of larger tissue volumes. Therefore, ROLL cannot replace WGL as the standard of care.
机译:对于不可触及的乳腺癌的治疗,准确的术前定位对于实现完全切除并获得最佳的美容效果至关重要。放射性隐匿性病变的定位(ROLL)使用放射性示踪剂,在肿瘤内注射以识别前哨淋巴结,以指导手术切除原发肿瘤。在一项多中心随机对照试验中,我们确定ROLL是否优于术前肿瘤定位的护理标准(即线引导定位,WGL)。经组织学证实为不可触及的乳腺癌且有资格接受前哨淋巴结保乳治疗的女性(> 18岁)被随机分为ROLL或WGL。分配给ROLL的患者接受的肿瘤内剂量为120 Mbq--99 m纳米胶体。在伽马探针检测的指导下,通过外科手术切除了肿瘤。在WGL组中,超声或X线摄影术指导下的钩状导线插入为切除原发肿瘤提供了手术指导。主要的结局指标是完全切除肿瘤的比例(即切缘阴性),需要再次切除的患者比例和切除的组织量。根据意向性治疗原则分析数据。该研究在ClinincalTrials.gov上注册,编号为NCT00539474。总共招募了314名患有316种浸润性乳腺癌的患者。 ROLL组的140/162(86%)患者与WGL组的134/152(88%)患者实现了肿瘤完全清除且切缘阴性(P = 0.644)。 ROLL组中有19/162(12%)的患者需要再次切除,而WGL组中有15/152(10%)(P = 0.587)的患者需要再次行切除术。 ROLL臂的标本体积明显大于WGL臂(71 vs. 64 cm3 ,P = 0.017)。在放射线和外科手术的持续时间和难度,前哨淋巴结手术的成功率和美容结局方面均未见明显差异。在这第一例经组织学证实的乳腺癌患者中,ROLL与WGL的多中心随机对照比较中,就肿瘤的完全切除率和再切除率而言,ROLL与WGL相当。但是,ROLL会导致切除更大的组织。因此,ROLL不能取代WGL作为护理标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号